State Street’s Ovid Therapeutics OVID Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$74.9K Sell
227,033
-1,145,075
-83% -$378K ﹤0.01% 4026
2025
Q1
$428K Sell
1,372,108
-22,410
-2% -$6.99K ﹤0.01% 3628
2024
Q4
$1.3M Buy
1,394,518
+33,063
+2% +$30.9K ﹤0.01% 3429
2024
Q3
$1.61M Buy
1,361,455
+7,084
+0.5% +$8.36K ﹤0.01% 3390
2024
Q2
$1.04M Buy
1,354,371
+198,724
+17% +$153K ﹤0.01% 3468
2024
Q1
$3.52M Buy
1,155,647
+35,300
+3% +$108K ﹤0.01% 3068
2023
Q4
$3.61M Buy
1,120,347
+11,288
+1% +$36.3K ﹤0.01% 3099
2023
Q3
$4.26M Buy
1,109,059
+82,428
+8% +$317K ﹤0.01% 2993
2023
Q2
$3.37M Buy
1,026,631
+834,898
+435% +$2.74M ﹤0.01% 3185
2023
Q1
$495K Hold
191,733
﹤0.01% 3748
2022
Q4
$357K Hold
191,733
﹤0.01% 3885
2022
Q3
$353K Hold
191,733
﹤0.01% 3906
2022
Q2
$412K Hold
191,733
﹤0.01% 3907
2022
Q1
$602K Buy
191,733
+46,884
+32% +$147K ﹤0.01% 3970
2021
Q4
$465K Hold
144,849
﹤0.01% 4053
2021
Q3
$487K Sell
144,849
-12,000
-8% -$40.3K ﹤0.01% 3989
2021
Q2
$613K Sell
156,849
-1,047,516
-87% -$4.09M ﹤0.01% 3790
2021
Q1
$4.84M Buy
1,204,365
+464,925
+63% +$1.87M ﹤0.01% 3069
2020
Q4
$1.71M Buy
739,440
+12,208
+2% +$28.2K ﹤0.01% 3419
2020
Q3
$4.17M Sell
727,232
-8,724
-1% -$50.1K ﹤0.01% 2870
2020
Q2
$5.42M Buy
+735,956
New +$5.42M ﹤0.01% 2722
2019
Q2
Sell
-187,915
Closed -$333K 3839
2019
Q1
$333K Buy
187,915
+18,100
+11% +$32.1K ﹤0.01% 3510
2018
Q4
$411K Sell
169,815
-13,949
-8% -$33.8K ﹤0.01% 3473
2018
Q3
$1.04M Buy
183,764
+43,020
+31% +$244K ﹤0.01% 3403
2018
Q2
$1.1M Buy
140,744
+35,016
+33% +$273K ﹤0.01% 3389
2018
Q1
$747K Buy
105,728
+30,162
+40% +$213K ﹤0.01% 3381
2017
Q4
$748K Buy
75,566
+3,631
+5% +$35.9K ﹤0.01% 3396
2017
Q3
$616K Buy
71,935
+22,335
+45% +$191K ﹤0.01% 3447
2017
Q2
$520K Buy
+49,600
New +$520K ﹤0.01% 3413